Tag: Drug Approvals
FDA Approves Probuphine Implant for Opioid Dependence
New form of treatment designed to last six months
FDA Approves Tecentriq to Treat Urothelial Carcinoma
FDA also approves a companion test to detect PD-L1 protein expression levels in patients
FDA Approves Nuplazid for Parkinson’s Hallucinations
Half of patients with Parkinson's may experience hallucinations, delusions
Doctors Can Be Misled About FDA ‘Breakthrough’ Drug Designation
Many believe meds supported by stronger evidence than the law requires to achieve designation
FDA Approves Venclexta for CLL With 17p Deletion
Drug sanctioned for chronic lymphocytic leukemia in patients with a specific chromosomal abnormality
FDA Approves First Leadless Pacemaker
Eliminates need to repair wire lead in typical pacemakers that can malfunction
FDA Approves Inflectra as ‘Biosimilar’ to Remicade
For adults with Crohn's, rheumatoid arthritis, or psoriasis
FDA Approves First Tx for Disease Linked to Stem Cell Transplant
Hepatic veno-occlusive disease is rare, but fatal
FDA Approves Cinqair for Severe Asthma
Lab-developed interleukin-5 antagonist monoclonal antibody helps reduce blood levels of eosinophils
FDA Approves Anthim for Treating Inhalation Anthrax
Anthim, combined with certain antibacterial drugs, designed to neutralize anthrax toxins
